RE:News Macer wrote: Same topic just not promoting responses to the clowns responses.
Very significant news in that they have now made a final decision on the PDC to move forward with into production. Production for both continued pre-clinical research on toxicology and human clinical trials.
Anyone ever heard of deals being inked at these conferences?
Two divisions (anti-cancer and therapuetic) should be plenty for this small company to chew on for the next few years. Especially if the anti-cancer takes off with human trials and alternate cancer targets. Would be a decent time to look at spinning off the anti-microbial side of the business.
Any idea of a possible suitor is also attending this conference?
Yes, you can call that a pump. But it is also my intuitiion speaking. Roger is very suave and he has been walking the walk lately. Something tells me he is working on something.
Macer
I wonder if there are examples of early bio deals that we could look at. Preclinical. Phase 1?
I suppose with my belief in the science and belief that human clinicals will be successful, I'd rather not see a deal this year. More value for shareholders if we prove the science first.